Center for Scientific Review; Notice of Closed Meetings, 15022-15023 [2013-05365]

Download as PDF 15022 Federal Register / Vol. 78, No. 46 / Friday, March 8, 2013 / Notices information for this meeting, including the agenda, will be available at http:// smrb.od.nih.gov. To sign up for public comment, please submit your name and affiliation to the contact person listed below by March 18, 2013. Sign up will be restricted to one sign up per email. In the event that time does not allow for all those interested to present oral comments, anyone may file written comments using the contact person address below. The toll-free number to participate in the teleconference is 877–891–6972. Indicate to the conference operator that your Participant pass code is ‘‘NIH’’. Place: National Institutes of Health, Office of the Director, NIH, Office of Science Policy, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Juanita Marner, Office of Science Policy, Office of the Director, NIH, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, smrb@mail.nih.gov, (301) 435–1770. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. The draft meeting agenda, meeting materials, dial-in information, and other information about the SMRB, will be available at http:// smrb.od.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: March 4, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–05370 Filed 3–7–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Office of AIDS Research Advisory Council. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other VerDate Mar<15>2010 18:44 Mar 07, 2013 Jkt 229001 reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Office of AIDS Research Advisory Council. Date: April 11, 2013. Time: 8:30 a.m. to 5:00 p.m. Agenda: The topic of the meeting will be HIV-associated Neurological Manifestations and Disorders. The speakers at this meeting will focus on the scientific progress and opportunities for research on: the epidemiology, diagnosis, assessment, treatment, and prevention of Neuro-AIDS and HIV-associated neurological disorders. The speakers also will highlight research on peripheral neuropathies in the ART era; HIVassociated neuropathogenesis; neuroimaging; host and viral genetics factors increasing vulnerability to Neuro-AIDS; CNS compartmentalization and challenges for an HIV cure; CNS-targeted ARV therapeutics; and neuroprotective strategies. An update will be provided on the latest changes made to the Federal HIV treatment and prevention guidelines by the OARAC Working Groups responsible for the guidelines. Place: National Institutes of Health, 5635 Fishers Lane Conference Center, Terrace Level, Suite T–500, Rockville, MD 20852. Contact Person: Robert Eisinger, Ph.D., Executive Secretary, Director of Scientific and Program Operations, Office of Aids Research, Office of the Director, NIH, 5635 Fishers Lane, Msc 9310, Suite 400, Rockville, MD 20852, (301) 496–0357; be4y@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.oar.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: March 4, 2013. Melanie J. Gray, Program Analyst, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2013–05364 Filed 3–7–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Infectious Diseases and Microbiology—AREA Review. Date: March 19, 2013. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Richard G Kostriken, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 20892, 301–402– 4454, kostrikr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Vascular Disease Pathobiology. Date: March 29, 2013. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Anshumali Chaudhari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4124, MSC 7802, Bethesda, MD 20892, (301) 435– 1210, chaudhaa@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–RM– 12–014: Extracellular RNA in Therapy. Date: March 29, 2013. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Nywana Sizemore, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 20892, 301–435– 1718, sizemoren@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; E:\FR\FM\08MRN1.SGM 08MRN1 Federal Register / Vol. 78, No. 46 / Friday, March 8, 2013 / Notices 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: March 4, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–05365 Filed 3–7–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Health Assessment and Translation Webinar on the Assessment of Data Quality in Animal Studies; Notice of Public Webinar and Registration Information SUMMARY: The National Toxicology Program (NTP) announces a public, web-based meeting on the assessment of data quality in animal studies. The Office of Health Assessment and Translation (OHAT), Division of the National Toxicology Program (DNTP), National Institute of Environmental Health Sciences (NIEHS) will host the web-based meeting using Adobe® Connect TM and the public can register to attend. DATES: Registration for web-based meeting: Deadline is March 18, 2013. Meeting: March 20, 2013, 2:00–4:30 p.m. Eastern Daylight Time (EDT). Registrants will receive information by email to access the web-based meeting on or before March 19, 2013. ADDRESSES: Agency Web site: The agenda, registration, and other information are available at http://ntp.niehs.nih.gov/go/ 38752. FOR FURTHER INFORMATION CONTACT: Dr. Andrew Rooney, Deputy Director, OHAT, DNTP, NIEHS, P.O. Box 12233, K2–04, Research Triangle Park, NC 27709. Phone: 919–541–2999, Fax: 301– 480–3299, Email: Andrew.Rooney@nih.gov. mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Background: The OHAT, DNTP, NIEHS, has led an effort for the NTP to develop an approach to carry out literature-based health assessments that incorporates systematic review methodology (available at http:// ntp.niehs.nih.gov/go/38673). The NTP plans to hold a series of web-based, public meetings with a focus on methodological issues related to OHAT implementing systematic review. The first will focus on the assessment of VerDate Mar<15>2010 18:44 Mar 07, 2013 Jkt 229001 data quality in animal studies. The meeting will begin with invited presentations related to the assessment of study quality followed by a general discussion period. Webinar and Registration: The OHAT will host a web-based, public meeting on the assessment of data quality in animal studies on March 20, 2013, 2:00– 4:30 p.m. EDT. The public may register for the webinar at http:// ntp.niehs.nih.gov/go/38752. The deadline for registration for the webinar is March 18. Registrants will receive information by email to access the webbased meeting (via Adobe® Connect TM) on or before March 19, 2013. The preliminary agenda is available at http://ntp.niehs.nih.gov/go/38752. Registrants are encouraged to access the Web site to stay abreast of current information about this event. Public Participation: The meeting will be interactive with opportunities for the public to ask presenters specific questions and participate in the general discussion period. Instructions for participating in the meeting using Adobe® Connect TM will be included in the information for accessing the webinar. Individuals with disabilities who need accommodations to participate in this event should contact Dr. Andrew Rooney (See FOR FURTHER INFORMATION CONTACT). TTY users should contact the Federal TTY Relay Service at (800) 877–8330. Requests should be made at least 5 business days in advance of the web-based meeting. Background Information on OHAT: OHAT was established to serve as an environmental health resource to the public and regulatory and health agencies (http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3094430). This office conducts evaluations to assess the evidence that environmental chemicals, physical substances, or mixtures (collectively referred to as ‘‘substances’’) cause adverse health effects and provides opinions on whether these substances may be of concern given what is known about current human exposure levels. OHAT also organizes workshops or state-of-the-science evaluations to address issues of importance in environmental health sciences. OHAT assessments are published as NTP Monographs. Information about OHAT is found at http://ntp.niehs.nih.gov/go/ohat. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel Cancer Causation & Emergence, Underlying Risk Factors and Prevention Mechanisms. Date: April 10–11, 2013. Time: 7:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hillton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NHH, 6116 Executive Blvd., Room 8050A, Bethesda, MD 20892–8328, 301–402– 9415, schweinfestcw@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: March 4, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–05366 Filed 3–7–13; 8:45 am] BILLING CODE 4140–01–P Dated: March 4, 2013. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2013–05406 Filed 3–7–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00065 Fmt 4703 Sfmt 9990 15023 E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 78, Number 46 (Friday, March 8, 2013)]
[Notices]
[Pages 15022-15023]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05365]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Infectious Diseases and Microbiology--AREA Review.
    Date: March 19, 2013.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Richard G Kostriken, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 
20892, 301-402-4454, kostrikr@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Vascular Disease Pathobiology.
    Date: March 29, 2013.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Anshumali Chaudhari, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4124, MSC 7802, Bethesda, MD 
20892, (301) 435-1210, chaudhaa@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA-RM-12-014: Extracellular RNA in Therapy.
    Date: March 29, 2013.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Nywana Sizemore, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 
20892, 301-435-1718, sizemoren@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine;

[[Page 15023]]

93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 
93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of 
Health, HHS)

    Dated: March 4, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-05365 Filed 3-7-13; 8:45 am]
BILLING CODE 4140-01-P